These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38740304)

  • 21. Risk Factors for Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae (CP-CRE) Acquisition Among Contacts of Newly Diagnosed CP-CRE Patients.
    Schwartz-Neiderman A; Braun T; Fallach N; Schwartz D; Carmeli Y; Schechner V
    Infect Control Hosp Epidemiol; 2016 Oct; 37(10):1219-25. PubMed ID: 27452597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carbapenem-resistant
    Ruvinsky S; Voto C; Roel M; Deschutter V; Ferraro D; Aquino N; Reijtman V; Galvan ME; Motto E; García M; Sarkis C; Bologna R
    Front Public Health; 2022; 10():983174. PubMed ID: 36091556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and Molecular Epidemiology of Carbapenem-Resistant Enterobacteriaceae Among Adult Inpatients in Singapore.
    Marimuthu K; Venkatachalam I; Khong WX; Koh TH; Cherng BPZ; Van La M; De PP; Krishnan PU; Tan TY; Choon RFK; Pada SK; Lam CW; Ooi ST; Deepak RN; Smitasin N; Tan EL; Lee JJ; Kurup A; Young B; Sim NTW; Thoon KC; Fisher D; Ling ML; Peng BAS; Teo YY; Hsu LY; Lin RTP; Ong RT; Teo J; Ng OT;
    Clin Infect Dis; 2017 May; 64(suppl_2):S68-S75. PubMed ID: 28475792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multicenter Study of the Risk Factors for Colonization or Infection with Carbapenem-Resistant Enterobacteriaceae in Children.
    Chiotos K; Tamma PD; Flett KB; Naumann M; Karandikar MV; Bilker WB; Zaoutis T; Han JH
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in the prevalence of causative pathogens isolated from severe burn patients from 2012 to 2017.
    Park JJ; Seo YB; Choi YK; Kym D; Lee J
    Burns; 2020 May; 46(3):695-701. PubMed ID: 31630835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carbapenem-resistant Enterobacteriaceae colonization and infection in critically ill patients: a retrospective matched cohort comparison with non-carriers.
    Dickstein Y; Edelman R; Dror T; Hussein K; Bar-Lavie Y; Paul M
    J Hosp Infect; 2016 Sep; 94(1):54-9. PubMed ID: 27392978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening of nursing home residents for colonization with carbapenem-resistant Enterobacteriaceae admitted to acute care hospitals: Incidence and risk factors.
    Cunha CB; Kassakian SZ; Chan R; Tenover FC; Ziakas P; Chapin KC; Mermel LA
    Am J Infect Control; 2016 Feb; 44(2):126-30. PubMed ID: 26631643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence and predictors of health care-associated infections among patients colonized with carbapenem-resistant Enterobacteriaceae.
    Correa AAF; Fortaleza CMCB
    Am J Infect Control; 2019 Feb; 47(2):213-216. PubMed ID: 30279017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence of a subsequent carbapenem-resistant Enterobacteriaceae infection after previous colonisation or infection: a prospective cohort study.
    Tang SSL; Chee E; Teo JQ; Chlebicki MP; Kwa ALH
    Int J Antimicrob Agents; 2021 Jun; 57(6):106340. PubMed ID: 33857538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors for carbapenem-resistant Enterobacterales infection among hospitalized patients with previous colonization.
    Chen X; Zhou M; Yan Q; Jian Z; Liu W; Li H
    J Clin Lab Anal; 2022 Nov; 36(11):e24715. PubMed ID: 36181301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transmission of Carbapenem-Resistant Enterobacterales in an Overcrowded Emergency Department: Controlling the Spread to the Hospital.
    Salomão MC; Freire MP; Lázari CS; Cury AP; Rossi F; Segurado AAC; Costa SF; Levin AS; Boszczowski Í;
    Clin Infect Dis; 2023 Jul; 77(Suppl 1):S46-S52. PubMed ID: 37406046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The importance of active surveillance of carbapenem-resistant Enterobacterales (CRE) in colonization rates in critically ill patients.
    Gomides MDA; Fontes AMS; Silveira AOSM; Matoso DC; Ferreira AL; Sadoyama G
    PLoS One; 2022; 17(1):e0262554. PubMed ID: 35051212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emergence and expansion of carbapenem resistant enterobacterales in the Western Cape Province, South Africa.
    Moloto K; Newton-Foot M; Whitelaw A; Dramowski A
    PLoS One; 2024; 19(8):e0309315. PubMed ID: 39186516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Risk Factors and Microbiological and Intestinal Characteristics of Carbapenemase-Producing
    Yuan W; Xu J; Guo L; Chen Y; Gu J; Zhang H; Yang C; Yang Q; Deng S; Zhang L; Deng Q; Wang Z; Ling B; Deng D
    Microbiol Spectr; 2022 Dec; 10(6):e0190621. PubMed ID: 36445086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Outcomes and Treatment Strategies in Patients With Non-Carbapenemase-producing Carbapenem-Resistant Versus Carbapenem-Susceptible Enterobacterales Infections.
    Debnath A; Pillinger KE; Martin AJ; Dobrzynski D; Cameron A; Shulder S
    Ann Pharmacother; 2023 Jul; 57(7):803-812. PubMed ID: 36268974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiology and risk factors of neurosurgical bacterial meningitis/encephalitis induced by carbapenem resistant Enterobacteriaceae.
    Guanghui Z; Jing L; Guojun Z; Hong L
    J Infect Chemother; 2020 Jan; 26(1):101-106. PubMed ID: 31445817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a risk prediction model for subsequent infection after colonization with carbapenem-resistant Enterobacterales: a retrospective cohort study.
    Zheng G; Cai J; Deng H; Yang H; Xiong W; Chen E; Bai H; He J
    Antimicrob Resist Infect Control; 2024 Apr; 13(1):46. PubMed ID: 38659068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of carbapenem-resistant Enterobacteriaceae (CRE) strains in patients with COVID-19 in the ICU ward: a retrospective case-control study.
    Vlad ND; Cernat RC; Carp S; Mitan R; Dumitru A; Nemet C; Voidăzan S; Rugină S; Dumitru IM
    J Int Med Res; 2022 Oct; 50(10):3000605221129154. PubMed ID: 36259133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rates of fecal transmission of extended-spectrum β-lactamase-producing and carbapenem-resistant Enterobacteriaceae among patients in intensive care units in Korea.
    Kim J; Lee JY; Kim SI; Song W; Kim JS; Jung S; Yu JK; Park KG; Park YJ
    Ann Lab Med; 2014 Jan; 34(1):20-5. PubMed ID: 24422191
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Germs of thrones - spontaneous decolonization of Carbapenem-Resistant Enterobacteriaceae (CRE) and Vancomycin-Resistant Enterococci (VRE) in Western Europe: is this myth or reality?
    Davido B; Moussiegt A; Dinh A; Bouchand F; Matt M; Senard O; Deconinck L; Espinasse F; Lawrence C; Fortineau N; Saleh-Mghir A; Caballero S; Escaut L; Salomon J
    Antimicrob Resist Infect Control; 2018; 7():100. PubMed ID: 30123500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.